Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample-Reference-Cited by-同舟云学术

Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample

Published:2008-05-16 Issue:4 Volume:114 Page:242-248
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zhao Chengquan,Austin R. Marshall

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. The Bethesda System for Reporting Cervical Cytology

2. Improving Papanicolaou test quality and reducing medical errors by using Toyota Production System Methods;Raab;Am J Obstet Gynecol.,2006

3. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses

4. Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears;Bos;Am J Clin Pathol.,2001

5. Longitudinal study of women with negative cervical smears according to endocervical status;Mitchell;Lancet,1991

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution;Cancer Cytopathology;2016-10-24

2. Follow-up Outcomes in a Large Cohort of Patients With HPV-Negative LSIL Cervical Screening Test Results;American Journal of Clinical Pathology;2015-04-01

3. Authors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals - A five year (2007-2011) experience;CytoJournal;2014-04-29

4. Low-Grade Squamous Intraepithelial Lesion/Cannot Exclude High-Grade Squamous Intraepithelial Lesion (LSIL-H) Is a Unique Category of Cytologic Abnormality Associated With Distinctive HPV and Histopathologic CIN 2+ Detection Rates;American Journal of Clinical Pathology;2014-02-01

5. Validity and Reliability of Using a Self-Lavaging Device for Cytology and HPV Testing for Cervical Cancer Screening: Findings from a Pilot Study;PLoS ONE;2013-12-20